ESC 365 - Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

ESC Premium Access

Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

Session: Poster session 1 - Treatment of dyslipidaemia

Topic: Drug therapy

Speaker: Professor A. Shek (Tashkent, UZ)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Aleksandr Shek

Specialized Cardiology Center of the Republic of Uzbekistan, Tashkent (Uzbekistan)

0 follower

3 more presentations in this session

Treatment and control of dyslipidemia among adults in northeastern China: results of the dyslipidemia international study (DYSIS)

Speaker: Doctor W. Zheng (Beijing, CN)

Anti-proprotein convertase subtilisin-kexin type 9 monoclonal antibodies: effects on lipid profile and arterial stiffness

Evaluation of statin users, people with hypercholesterolemia, and cardiovascular disease patients in the Japan Medical Data Center claims database

Speaker: Doctor K. Monda (Thousand Oaks, US)

Access the full session

Poster session 1 - Treatment of dyslipidaemia

Speakers: Professor A. Shek, Doctor W. Zheng, Doctor K. Monda

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by